Sectors
RVMD
Revolution Medicines, Inc.
203.00
1 x 185.86
1 x 218.54
bid
ask
-
4.88
2.35%
10:30 AM
timesize
| Ytd | 154.87% | |
| 1y | 434.64% |
200.53
day range
206.30
37.88
52 week range
224.31
| Open | 205.01 | Prev Close | 207.88 | Low | 200.53 | High | 206.30 | Mkt Cap | 43.52B |
| Vol | 383.38K | Avg Vol | 2.46M | EPS | -8.88 | P/E | N/A | Forward P/E | -33.55 |
| Beta | 1.39 | Short Ratio | 5.49 | Inst. Own | 101.04% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-04 | 50-d Avg | 192.80 | 200-d Avg | 130.48 | 1yr Est | 235.82 |
| Income Statement | |||
| Operating Expenses | 505.13M | ||
| Research and Development Expense | 394.92M | ||
| Selling, General and Administrative Expense | 110.21M | ||
| Operating Income | -505.13M | ||
| Interest Expense | 23.78M | ||
| Net Income | -644.37M | ||
| Net Income Common Stock | -644.37M | ||
| Net Income Common Stock (USD) | -644.37M | ||
| Consolidated Income | -644.37M | ||
| Earnings per Basic Share | -3.06 | ||
| Earnings per Basic Share (USD) | -3.06 | ||
| Earnings per Diluted Share | -3.06 | ||
| Earning Before Interest & Taxes (EBIT) | -620.59M | ||
| Earning Before Interest & Taxes (USD) | -620.59M | ||
| Weighted Average Shares | 210.89M | ||
| Weighted Average Shares Diluted | 210.89M | ||
| Balance Sheet | |||
| Cash and Equivalents | 820.29M | ||
| Cash and Equivalents (USD) | 820.29M | ||
| Investments | 3.16B | ||
| Investments Current | 3.12B | ||
| Investments Non-Current | 42.45M | ||
| Current Assets | 4.03B | ||
| Property, Plant & Equipment Net | 162.45M | ||
| Total Assets | 4.32B | ||
| Debt Current | 16.75M | ||
| Total Debt | 1.19B | ||
| Current Liabilities | 354.06M | ||
| Debt Non-Current | 1.17B | ||
| Total Liabilities | 1.72B | ||
| Accumulated Retained Earnings (Deficit) | -3.97B | ||
| Accumulated Other Comprehensive Income | -5.95M | ||
| Shareholders Equity | 2.61B | ||
| Shareholders Equity (USD) | 2.61B | ||
| Assets Non-Current | 294.93M | ||
| Total Debt (USD) | 1.19B | ||
| Goodwill and Intangible Assets | 70.41M | ||
| Liabilities Non-Current | 1.36B | ||
| Trade and Non-Trade Payables | 88.42M | ||
| Tax Liabilities | 2.35M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 4.50M | ||
| Net Cash Flow from Financing | 2.42B | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 374.50M | ||
| Capital Expenditure | -2.29M | ||
| Issuance (Purchase) of Equity Shares | 1.69B | ||
| Issuance (Repayment) of Debt Securities | 732.07M | ||
| Net Cash Flow from Investing | -1.66B | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -1.66B | ||
| Net Cash Flow from Operations | -387.32M | ||
| Share Based Compensation | 67.00M | ||